Skip to content
Screener

Enterprise value at other companies

Arvinas logo
ArvinasARVN
$599.29M+45.3%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$9.39B+233%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$1.99B+657%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.03B+1,325%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.77B+1,855%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$5.84B+181%

Other financials

Income statement

See full
Revenue$9.0M-79.5%
Operating income-$94.2M-95.0%
Net income-$89.5M-106%
EPS (diluted)-$0.81-55.8%

Balance sheet

See full
Cash & equivalents$68.7M-19.4%
Total debt$58.1M+12.0%
Total equity$402.6M-10.0%
Total assets$535.5M-9.5%

Cash flow

See full
Operating cash flow-$96.6M-52.9%
CapEx$1.9M-27.6%
Free cash flow-$98.5M-49.6%

Valuation

See full
Market cap$2.62B+227%
P/S71.2×+62.1×

Profitability

See full
Operating margin-982.4%-1,538pp
Net margin-928.4%-1,403pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-80.3%+113pp
Debt / equity0.1×0.0×
Current ratio6.3×-0.5×

Where this comes from

Calculated from Nurix Therapeutics, Inc.’s reported figures.

The source filing: Nurix Therapeutics, Inc.’s 8-K, filed July 9, 2026. Open the filing →

Filed
Jul 9, 2026, 4:09 PM EDT
Accession
0001549595-26-000038

FAQ

What is Nurix Therapeutics, Inc.'s enterprise value?
Nurix Therapeutics, Inc. (NRIX) reported enterprise value of $1.83B in Q1 2026.
How has Nurix Therapeutics, Inc.'s enterprise value changed year-over-year?
Nurix Therapeutics, Inc.'s enterprise value increased by 156.7% year-over-year, from $711.59M to $1.83B.
What is the long-term trend for Nurix Therapeutics, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s enterprise value has grown at a 0.7% compound annual growth rate (CAGR), from $1.55B to $1.6B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about Nurix Therapeutics, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude